Empowering investors with access to the best research, experts and opportunities.
A fast-growing Australian health and wellness company is eyeing a big piece of a very big pie that is getting close to being baked: Australia’s over-the-counter medicinal cannabis S3 market.
Australia is a little safer than it was in FY22 with ASX-listed Spectur this week announcing wins in beach safety, new tech ready for market, and a record start to revenue and sales in FY23.
As young, tech-savvy buyers gain market share, digitised and personalised services are becoming the norm. These consumers like to manage their lives from their phones, and they expect curated customer journeys to be available to them 24/7.
The domestic market opened down more than 2.5% from last night’s close, before clawing back initial losses to be down 2.37% by mid afternoon. The Australian dollar followed suit, down 2.26% to near 52-week lows.
Where global mining giants Barrick Gold (A$39 billion) and Newcrest (A$15 billion) stumbled and fell, a comparative minnow has hit the ground running – making history in the process.
The manager of our National Electricity Market has warned that we will soon start running short of power generation and transmission capacity, risking blackouts, unless we act fast.
ASX-listed biotech Prescient Therapeutics is crossing a major inflection point on the back of three milestone announcements made within a span of less than eight weeks – including one today.
ASX-listed Wellnex Life has started FY23 with a metaphorical muscle flex, announcing that all segments of its health and wellness business have experienced growth in the past two months.
Equity markets have resumed their downtrend after a brief rally, with the S&P/ASX 200 closing out its worst trading week since mid-June 3.9% lower.
Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In March, Pure Asset Management’s Tim Callan selected Comet Ridge as one of his favourite stocks, sharing some of his thoughts on…
Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In February, Westferry Investment Group’s Peter Johns selected XRF Scientific as one of his favourite stocks, pointing to the company’s significant market…
Many have written off the Jobs and Skills Summit as a talkfest, but let’s dare to dream that it might go some way towards bringing us together to tackle our shared economic challenges and kickstart a new era of national co-operation.
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.